{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:39:12Z","timestamp":1789915152209,"version":"4.0.1"},"update-to":[{"DOI":"10.1002\/14651858.cd010181","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2016,8,3]],"date-time":"2016-08-03T00:00:00Z","timestamp":1470182400000}}],"reference-count":187,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010181.pub2","type":"journal-article","created":{"date-parts":[[2016,8,3]],"date-time":"2016-08-03T15:37:03Z","timestamp":1470238623000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Platinum-induced hearing loss after treatment for childhood cancer"],"prefix":"10.1002","volume":"2019","author":[{"given":"Jorrit W","family":"van As","sequence":"first","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology; c\/o Cochrane Childhood Cancer; Heidelberglaan 25 Utrecht Netherlands 3584 CS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk","family":"van den Berg","sequence":"additional","affiliation":[{"name":"Emma Children's Hospital, Amsterdam UMC, University of Amsterdam; Department of Paediatric Oncology; PO Box 22660 Amsterdam Netherlands 1100 DD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira C","family":"van Dalen","sequence":"additional","affiliation":[{"name":"Princess M\u00e1xima Center for Pediatric Oncology; Heidelberglaan 25 Utrecht Netherlands 3584 CS"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,8,3]]},"reference":[{"issue":"10","key":"10.1002\/14651858.CD010181.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/01.mph.0000141348.62532.73","article-title":"Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss","volume":"26","author":"Bertolini","year":"2004","journal-title":"Journal of Pediatric Hematology\/Oncology"},{"issue":"13","key":"10.1002\/14651858.CD010181.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1200\/JCO.2004.08.015","article-title":"Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study - Pediatric Oncology Group 9049 and Children's Cancer Group 8882","volume":"22","author":"Cushing","year":"2004","journal-title":"Journal of Clinical Oncology"},{"issue":"22","key":"10.1002\/14651858.CD010181.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"2371-81 Erratum","DOI":"10.1001\/jama.2013.6296","article-title":"Clinical ascertainment of health outcomes among adults treated for childhood cancer","volume":"309","author":"Hudson","year":"2013","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD010181.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/pbc.21898","article-title":"Analysis of ototoxicity in young children receiving carboplatin in the context of conservative management of unilateral or bilateral retinoblastoma","volume":"52","author":"Jehanne","year":"2009","journal-title":"Pediatric Blood & Cancer"},{"issue":"2","key":"10.1002\/14651858.CD010181.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ijrobp.2013.09.046","article-title":"Quality of survival and growth in children and young adults in the PNET4 European controlled trial of hyperfractionated versus conventional radiation therapy for standard-risk medulloblastoma","volume":"88","author":"Kennedy","year":"2014","journal-title":"International Journal of Radiation Oncology Biology Physics"},{"issue":"2","key":"10.1002\/14651858.CD010181.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/pbc.21155","article-title":"A retrospective review of hearing in children with retinoblastoma treated with carboplatin-based chemotherapy","volume":"50","author":"Lambert","year":"2008","journal-title":"Pediatric Blood & Cancer"},{"issue":"6","key":"10.1002\/14651858.CD010181.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1200\/JCO.2013.51.2038","article-title":"Ototoxicity in children with high-risk neuroblastoma: prevalence, risk factors, and concordance of grading scales - a report from the Children's Oncology Group","volume":"32","author":"Landier","year":"2014","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"10.1002\/14651858.CD010181.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0360-3016(98)00501-X","article-title":"There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy","volume":"43","author":"Mandell","year":"1999","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"11","key":"10.1002\/14651858.CD010181.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/pbc.25123","article-title":"Incidence of platinum-induced ototoxicity in pediatric patients in Quebec","volume":"61","author":"Peleva","year":"2014","journal-title":"Pediatric Blood & Cancer"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1056\/NEJMoa0810613","article-title":"Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma","volume":"361","author":"Perilongo","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD010181.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0002-9394(02)01348-X","article-title":"Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation","volume":"133","author":"Shields","year":"2002","journal-title":"American Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1016\/j.ophtha.2006.06.018","article-title":"The International Classification of Retinoblastoma Predicts Chemoreduction Success","volume":"113","author":"Shields","year":"2006","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD010181.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1055\/s-2002-33179","article-title":"The incidence of hearing impairment after successful treatment of neuroblastoma","volume":"214","author":"Simon","year":"2002","journal-title":"Klinische Padiatrie"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/pbc.22027","article-title":"Health status at long-term follow-up in patients treated for extremity localized Ewing sarcoma or osteosarcoma: a Scandinavian Sarcoma Group Study","volume":"53","author":"Aksnes","year":"2009","journal-title":"Pediatric Blood & Cancer"},{"issue":"12","key":"10.1002\/14651858.CD010181.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/pbc.24580","article-title":"High-BMI at diagnosis is associated with inferior survival in patients with osteosarcoma: a report from the Children's Oncology Group","volume":"60","author":"Altaf","year":"2013","journal-title":"Pediatric Blood & Cancer"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0016|cit16","first-page":"1008","article-title":"Hearing loss in pediatric oncology patients cisplatin regimens","author":"Ansari","year":"2010","journal-title":"Pediatric Blood & Cancer"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0017|cit17","unstructured":"Armstrong GT Conklin H Huang S Gajjar A Merchant TE Hudson M Long-term survival & health outcomes after diagnosis of low grade glioma (ii30) International Symposium on Pediatric Neuro-Oncology 2010"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1016\/j.ejca.2005.08.026","article-title":"Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy","volume":"41","author":"Bacci","year":"2005","journal-title":"European Journal of Cancer"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJMoa1001527","article-title":"Outcome after reduced chemotherapy for intermediate-risk neuroblastoma","volume":"363","author":"Baker","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD010181.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/pbc.24830","article-title":"Concordance between the Chang and the International Society of Pediatric Oncology (SIOP) ototoxicity grading scales in patients treated with cisplatin for medulloblastoma","volume":"61","author":"Bass","year":"2014","journal-title":"Pediatric Blood & Cancer"},{"issue":"11","key":"10.1002\/14651858.CD010181.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1002\/pbc.25618","article-title":"Ototoxicity in retinoblastoma survivors treated with carboplatin based chemotherapy: a cross-sectional study of 116 patients","volume":"62","author":"Batra","year":"2015","journal-title":"Pediatric Blood & Cancer"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1470-2045(05)70291-6","article-title":"Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial","volume":"6","author":"Berthold","year":"2005","journal-title":"Lancet Oncology"},{"issue":"9","key":"10.1002\/14651858.CD010181.pub2-BIB0023|cit23","first-page":"1157","article-title":"Cisplatin, vinblastine, and bleomycin (CVB) therapy for relapsed disseminated neuroblastoma","volume":"68","author":"Bostrom","year":"1984","journal-title":"Cancer Treatment Reports"},{"issue":"12","key":"10.1002\/14651858.CD010181.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/0014-2964(79)90032-X","article-title":"E.O.R.T.C. phase II study of cisplatin in cyvadic-resistant soft tissue sarcoma","volume":"15","author":"Bramwell","year":"1979","journal-title":"European Journal of Cancer"},{"issue":"22","key":"10.1002\/14651858.CD010181.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1002\/cncr.29604","article-title":"Treatment-induced hearing loss and adult social outcomes in survivors of childhood CNS and non-CNS solid tumors: results from the St. Jude Lifetime Cohort Study","volume":"121","author":"Brinkman","year":"2015","journal-title":"Cancer"},{"issue":"5","key":"10.1002\/14651858.CD010181.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/mpo.2950160517","article-title":"Ototoxicity of high-dose cis-platinum in children","volume":"16","author":"Brock","year":"1988","journal-title":"Medical and Pediatric Oncology"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/mpo.2950190415","article-title":"Cisplatin ototoxicity in children: a practical grading system","volume":"19","author":"Brock","year":"1991","journal-title":"Medical and Pediatric Oncology"},{"issue":"24","key":"10.1002\/14651858.CD010181.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1200\/JCO.2005.04.6979","article-title":"Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials","volume":"24","author":"Buckner","year":"2006","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0029|cit29","unstructured":"Calvo D Pat YZ Wallace S Hersch EM Benjamin RS Pritchard J Phase I trial of percutaneous intra-arterial (IA) cis-diammine dichloride platinum II (CDDP) for regionally confined malignancies (C-558) Proceedings of the American Association for Cancer Research 1979"},{"issue":"8","key":"10.1002\/14651858.CD010181.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/pds.1772","article-title":"Adverse drug reaction active surveillance: developing a national network in Canada's children's hospitals","volume":"18","author":"Carleton","year":"2009","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"2","key":"10.1002\/14651858.CD010181.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/clpt.2014.90","article-title":"Response to \"Evaluation of pharmacogenetic markers to predict the risk of cisplatin-induced ototoxicity\"","volume":"96","author":"Carleton","year":"2014","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD010181.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/clpt.2013.219","article-title":"Role of TPMT and COMT genetic variation in cisplatin-induced ototoxicity","volume":"95","author":"Carleton","year":"2014","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/cncr.24884","article-title":"Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study","volume":"116","author":"Carr","year":"2010","journal-title":"Cancer"},{"issue":"1","key":"10.1002\/14651858.CD010181.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/mpo.2950240107","article-title":"Treatment of stage III neuroblastoma with emphasis on intensive induction chemotherapy: a report from the Neuroblastoma Group of the Spanish Society of Pediatric Oncology","volume":"24","author":"Castel","year":"1995","journal-title":"Medical and Pediatric Oncology"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1200\/JCO.2009.24.4228","article-title":"Practical grading system for evaluating cisplatin ototoxicity in children","volume":"28","author":"Chang","year":"2010","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/cncr.11952","article-title":"Results of a prospective study for the treatment of retinoblastoma","volume":"100","author":"Chantada","year":"2004","journal-title":"Cancer"},{"issue":"18","key":"10.1002\/14651858.CD010181.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1016\/j.ejca.2014.10.006","article-title":"Outcome of 3-day bleomycin, etoposide and cisplatin chemotherapeutic regimen for patients with malignant ovarian germ cell tumours: a Taiwanese Gynecologic Oncology Group study","volume":"50","author":"Chen","year":"2014","journal-title":"European Journal of Cancer"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000120545","article-title":"Ototoxic effect of cisplatin in children with brain tumors","volume":"16","author":"Cohen","year":"1991","journal-title":"Pediatric Neurosurgery"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0039|cit39","unstructured":"Corder MP Leimert JT Panther SK Elliott TE A phase II study of cis-platinum II diamminedichloride (CPDD) in lymphoma (C-38) Proceedings of the American Association for Cancer Research 1979"},{"issue":"12","key":"10.1002\/14651858.CD010181.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1200\/JCO.1997.15.12.3433","article-title":"NB87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric Oncology","volume":"15","author":"Coze","year":"1997","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0041|cit41","first-page":"911","article-title":"Evaluation of cisplatin in children with recurrent brain tumors","volume":"69","author":"Diez","year":"1985","journal-title":"Cancer Treatment Reports"},{"issue":"3","key":"10.1002\/14651858.CD010181.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"e363","DOI":"10.1016\/j.ijrobp.2012.03.066","article-title":"Learning and memory following conformal radiation therapy for pediatric craniopharyngioma and low-grade glioma","volume":"84","author":"Pinto","year":"2012","journal-title":"International Journal of Radiation Oncology Biology Physics"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0043|cit43","first-page":"373","article-title":"Chemotherapy of regional or metastatic neuroblastoma with high-dose cisplatin by continuous intravenous infusion and etoposide","volume":"15","author":"Dominici","year":"1989","journal-title":"Rivista Italiana di Pediatria"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1200\/JCO.2006.05.6184","article-title":"Bleomycin, etoposide, and cisplatin for three cycles compared with etoposide and cisplatin for four cycles in good-risk germ cell tumors: is there a preferred regimen?","volume":"24","author":"Einhorn","year":"2006","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"10.1002\/14651858.CD010181.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMoa067749","article-title":"High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors","volume":"357","author":"Einhorn","year":"2007","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1097\/FPC.0b013e328313aaa4","article-title":"Relations between polymorphisms in drug-metabolising enzymes and toxicity of chemotherapy with cyclophosphamide, thiotepa and carboplatin","volume":"18","author":"Ekhart","year":"2008","journal-title":"Pharmacogenetics and Genomics"},{"issue":"4","key":"10.1002\/14651858.CD010181.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/1097-0142(19940215)73:4<1297::AID-CNCR2820730427>3.0.CO;2-#","article-title":"A phase II study of carboplatin in children with recurrent or progressive solid tumors. A report from the Childrens Cancer Group","volume":"73","author":"Ettinger","year":"1994","journal-title":"Cancer"},{"issue":"5","key":"10.1002\/14651858.CD010181.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1055\/s-2004-821288","article-title":"Goal and results of the COSS study","volume":"36","author":"Flege","year":"2004","journal-title":"Handchirurgie, Mikrochirurgie, Plastische Chirurgie"},{"issue":"6","key":"10.1002\/14651858.CD010181.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1200\/JCO.2003.02.075","article-title":"Quality of life in good prognosis patients with metastatic germ cell cancer: a prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group\/Medical Research Council Testicular Cancer Study Group (30941\/TE20)","volume":"21","author":"Foss\u00e5","year":"2003","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"7152","DOI":"10.1200\/JCO.2005.01.214","article-title":"Intellectual and functional outcome of children 3 years old or younger who have CNS malignancies","volume":"23","author":"Fouladi","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"16","key":"10.1002\/14651858.CD010181.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/jnci\/djp238","article-title":"The legacy of cancer therapy in children","volume":"101","author":"Fox","year":"2009","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1023\/A:1008391103132","article-title":"Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs","volume":"9","author":"Fuchs","year":"1998","journal-title":"Annals of Oncology"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1055\/s-2008-1043805","article-title":"Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma: a report of the German cooperative pediatric liver tumor study HB 89 and HB 94","volume":"211","author":"Fuchs","year":"1999","journal-title":"Klinische Padiatrie"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0054|cit54","unstructured":"Gaynon P Baum E Greenberg L Krivit W Hammond D Taylor S A phase II trial of cis-platinum diammine dichloride (DDP) (NSC 119825) in refractory childhood tumors: a CCSG trial (C-424) Proceedings of the American Association for Cancer Research 1979"},{"issue":"10","key":"10.1002\/14651858.CD010181.pub2-BIB0055|cit55","first-page":"442","article-title":"Delayed platinum diamminodichloride toxicity in patients with germ tumors of the gonads","volume":"82","author":"Germ\u00e0 Lluch","year":"1984","journal-title":"Medicina Clinica"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1055\/s-2004-832355","article-title":"Low grade chiasmatic-hypothalamic glioma - carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy: Report from the multicenter treatment study for children and adolescents with a low grade glioma - HIT-LGG 1996 - of the Society of Pediatric Oncology and Hematology (GPOH)","volume":"216","author":"Gnekow","year":"2004","journal-title":"Klinische P\u00e4diatrie"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0057|cit57","first-page":"247","article-title":"Non-testicular germ cell tumors: analysis of the MAKEI 83\/86 therapy study and protocol changes for the follow-up study","volume":"201","author":"Gobel","year":"1989","journal-title":"Klinische Padiatrie"},{"issue":"2","key":"10.1002\/14651858.CD010181.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/1040-8428(90)90001-9","article-title":"Treatment of germ cell tumors in children: results of European trials for testicular and non-testicular primary sites","volume":"10","author":"G\u00f6bel","year":"1990","journal-title":"Critical Reviews in Oncology\/Hematolology"},{"issue":"20","key":"10.1002\/14651858.CD010181.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1200\/JCO.2008.16.5324","article-title":"Chemotherapy for the treatment of children and adolescents with malignant germ cell tumors","volume":"26","author":"Green","year":"2008","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"10.1002\/14651858.CD010181.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"e938","DOI":"10.1542\/peds.2009-1597","article-title":"Auditory late effects of childhood cancer therapy: a report from the Children's Oncology Group","volume":"125","author":"Grewal","year":"2010","journal-title":"Pediatrics"},{"issue":"10","key":"10.1002\/14651858.CD010181.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S1470-2045(06)70872-5","article-title":"High-dose chemotherapy in children with newly-diagnosed medulloblastoma","volume":"7","author":"Grill","year":"2006","journal-title":"Lancet Oncology"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"e1229","DOI":"10.1542\/peds.2007-0178","article-title":"Hearing loss, quality of life, and academic problems in long-term neuroblastoma survivors: a report from the Children's Oncology Group","volume":"120","author":"Gurney","year":"2007","journal-title":"Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD010181.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/neuonc\/not241","article-title":"Evaluation of amifostine for protection against cisplatin-induced serious hearing loss in children treated for average-risk or high-risk medulloblastoma","volume":"16","author":"Gurney","year":"2014","journal-title":"Neuro-Oncology"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.bone.2011.08.014","article-title":"Age as prognostic factor in patients with osteosarcoma","volume":"49","author":"Hagleitner","year":"2011","journal-title":"Bone"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"636405","DOI":"10.1155\/2012\/636405","article-title":"Survival trends and long-term toxicity in pediatric patients with osteosarcoma","volume":"2012","author":"Hagleitner","year":"2012","journal-title":"Sarcoma"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0066|cit66","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2012.30.15_suppl.10077","article-title":"Association of the genetic variants in the nucleotide excision repair genes XPA and XPC with cisplatin-induced hearing loss in patients with osteosarcoma (10077)","author":"Hagleitner","year":"2012","journal-title":"Annual Meeting of the American Society of Clinical Oncology"},{"issue":"12","key":"10.1002\/14651858.CD010181.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"e115869","DOI":"10.1371\/journal.pone.0115869","article-title":"Influence of genetic variants in TPMT and COMT associated with cisplatin induced hearing loss in patients with cancer: two new cohorts and a meta-analysis reveal significant heterogeneity between cohorts","volume":"9","author":"Hagleitner","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1002\/14651858.CD010181.pub2-BIB0068|cit68","first-page":"647","article-title":"Clinical studies of platinum coordination compounds in the treatment of various malignant diseases","volume":"59","author":"Hill","year":"1975","journal-title":"Cancer Chemotherapy Reports"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00383-010-2708-0","article-title":"Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: report from the JPLT","volume":"27","author":"Hishiki","year":"2011","journal-title":"Pediatric Surgery International"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0070|cit70","first-page":"816","article-title":"Outcome of hepatoblastoma treated with the JPLT-2 protocol from the experience of JPLT (Japanese Study Group for Pediatric Liver Tumor) study","author":"Hiyama","year":"2010","journal-title":"Pediatric Blood & Cancer"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0071|cit71","doi-asserted-by":"crossref","unstructured":"Hiyama E Kamimatsuse A Kamei N Watanabe K Hishiki T Tajiri T Cisplatin plus pirarubicin chemotherapy and combination ifomide, etoposide, pirarubicin, and carboplatin chemotherapy for hepatoblastoma Annual Meeting of the American Society of Clinical Oncology 2010","DOI":"10.1200\/jco.2010.28.15_suppl.9534"},{"issue":"10","key":"10.1002\/14651858.CD010181.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00383-013-3399-0","article-title":"A cisplatin plus pirarubicin-based JPLT2 chemotherapy for hepatoblastoma: experience and future of the Japanese Study Group for Pediatric Liver Tumor (JPLT)","volume":"29","author":"Hiyama","year":"2013","journal-title":"Pediatric Surgery International"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/mpo.10241","article-title":"Adrenocortical carcinoma in children: a role for etoposide and cisplatin adjuvant therapy? Preliminary report","volume":"40","author":"Hovi","year":"2003","journal-title":"Medical and Pediatric Oncology"},{"issue":"21","key":"10.1002\/14651858.CD010181.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1200\/JCO.2011.40.2792","article-title":"Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a children's oncology group phase I\/II study","volume":"30","author":"Jakacki","year":"2012","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0075|cit75","unstructured":"Khan A McCullough D Use of cis-platinum in CNS malignancy (C-144) Proceedings of the American Association for Cancer Research 1979"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0076|cit76","unstructured":"Kamalakar P Wang JJ Higby D Freeman AI Wallace HJ Clinical experience with CIS diammine dichloroplatinum (DDP) in children (C-188) Proceedings of the American Association for Cancer Research 1976"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2273.1986.tb00144.x","article-title":"Assessment of the effect of chemotherapy and radiotherapy on the auditory function of children with cancer","volume":"11","author":"Kingston","year":"1986","journal-title":"Clinical Otolaryngology and Allied Sciences"},{"issue":"2","key":"10.1002\/14651858.CD010181.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0360-3016(99)00369-7","article-title":"Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91","volume":"46","author":"Kortmann","year":"2000","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"issue":"10","key":"10.1002\/14651858.CD010181.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S1470-2045(13)70309-7","article-title":"Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial","volume":"14","author":"Kreissman","year":"2013","journal-title":"Lancet Oncology"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0080|cit80","first-page":"47","article-title":"Late effects of oncological therapy in children","volume":"64","author":"Kremers","year":"2003","journal-title":"Padiatrische Praxis"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0081|cit81","doi-asserted-by":"crossref","unstructured":"Landier W Knight KR Wong FL Lee JK Thomas O Kim H Ototoxicity in children with high-risk neuroblastoma: prevalence, risk factors, and concordance of grading scales - a report from the Children's Oncology Group (COG) (abstract number 9515) ASCO Annual Meeting 2011","DOI":"10.1200\/jco.2011.29.15_suppl.9515"},{"issue":"35","key":"10.1002\/14651858.CD010181.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1200\/JCO.2012.43.4951","article-title":"Yield of screening for long-term complications using the children's oncology group long-term follow-up guidelines","volume":"30","author":"Landier","year":"2012","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"10.1002\/14651858.CD010181.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/clpt.2014.67","article-title":"Evaluation of pharmacogenetic markers to predict the risk of cisplatin-induced ototoxicity","volume":"96","author":"Lanvers-Kaminsky","year":"2014","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1093\/jnci\/djp230","article-title":"Long-term outcomes in survivors of neuroblastoma: a report from the childhood cancer survivor study","volume":"101","author":"Laverdiere","year":"2009","journal-title":"Journal of the National Cancer Institute"},{"issue":"4","key":"10.1002\/14651858.CD010181.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.ejca.2006.10.023","article-title":"SFOP OS94: a randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients","volume":"43","author":"Deley","year":"2007","journal-title":"European Journal of Cancer"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0086|cit86","first-page":"553","article-title":"Carboplatin activity in cisplatin treated neuroblastoma","volume":"366","author":"Lewis","year":"1991","journal-title":"Advances in Neuroblastoma Research"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/jnci\/djk015","article-title":"Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup","volume":"99","author":"Lewis","year":"2007","journal-title":"Journal of the National Cancer Institute"},{"issue":"16","key":"10.1002\/14651858.CD010181.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1016\/j.ejca.2003.08.009","article-title":"Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose","volume":"40","author":"Li","year":"2004","journal-title":"European Journal of Cancer"},{"issue":"2","key":"10.1002\/14651858.CD010181.pub2-BIB0089|cit89","first-page":"191","article-title":"Clinical trials of cis-diamminedichloroplatinum (NSC-119875)","volume":"57","author":"Lippman","year":"1973","journal-title":"Cancer Chemotherapy Reports Part 1"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s13014-014-0274-7","article-title":"Nasopharyngeal carcinoma in children and adolescents - a single institution experience of 158 patients","volume":"9","author":"Liu","year":"2014","journal-title":"Radiation Oncology"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0091|cit91","unstructured":"Mahoney DH Jr Weaver T Steuber CP Starling KA Cis-platinum (CDDP) ototoxicity in pediatric patients Proceedings of the American Society of Clinical Oncology 1982"},{"issue":"6","key":"10.1002\/14651858.CD010181.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0022-3476(83)80747-1","article-title":"Ototoxicity with cisplatin therapy","volume":"103","author":"Mahoney","year":"1983","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0093|cit93","first-page":"163","article-title":"Health status of long term survivors after myeloablative therapy and bone marrow transplantation in children","volume":"18 Suppl 2","author":"Manfredini","year":"1996","journal-title":"Bone Marrow Transplantation"},{"issue":"22","key":"10.1002\/14651858.CD010181.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1200\/JCO.2000.18.22.3809","article-title":"The United Kingdom Children's Cancer Study Group's second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity","volume":"18","author":"Mann","year":"2000","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD010181.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11060-005-9049-1","article-title":"Ototoxicity of cisplatin plus standard radiation therapy vs. accelerated radiation therapy in glioblastoma patients","volume":"77","author":"Marshall","year":"2006","journal-title":"Journal of Neuro-Oncology"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1310\/hpj4209-801","article-title":"Doxorubicin, cisplatin, high-dose methotrexate, and ifosfamide for osteosarcoma","volume":"42","author":"Mbue","year":"2007","journal-title":"Hospital Pharmacy"},{"issue":"2","key":"10.1002\/14651858.CD010181.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0022-3476(83)80551-4","article-title":"Hearing loss in children receiving cisplatin chemotherapy","volume":"102","author":"McHaney","year":"1983","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1200\/JCO.2005.06.031","article-title":"Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and\/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate","volume":"23","author":"Meyers","year":"2005","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0099|cit99","first-page":"41","article-title":"Control of chronic symptoms. Secondary effects of treatments with radiotherapy and chemotherapy","volume":"28","author":"Montero","year":"2005","journal-title":"Oncologia"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0100|cit100","unstructured":"Nageswara RAA Wallace D Boyett J Gajjar A Packer RJ Cumulative cisplatin dose (CCD) does not correlate with event free (EFS) and overall survival (OS) outcomes in children with newly diagnosed average-risk medulloblastoma (ARMB) treated with cisplatin based adjuvant chemotherapy Annals of Neurology Conference 2011 S118 9"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0101|cit101","unstructured":"Nageswara Rao AA Wallace D Boyett J Gajjar A Packer RJ Cumulative cisplatin dose does not correlate with event-free and overall survival outcomes in children with newly diagnosed average-risk medulloblastoma treated with cisplatin-based adjuvant chemotherapy (PC-07) Annual Scientific Meeting of the Society for Neuro-Oncology 2011 iii96"},{"issue":"1","key":"10.1002\/14651858.CD010181.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/pbc.24670","article-title":"Cumulative cisplatin dose is not associated with event-free or overall survival in children with newly diagnosed average-risk medulloblastoma treated with cisplatin based adjuvant chemotherapy: report from the Children's Oncology Group","volume":"61","author":"Nageswara Rao","year":"2014","journal-title":"Pediatric Blood & Cancer"},{"issue":"7","key":"10.1002\/14651858.CD010181.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1200\/JCO.1991.9.7.1163","article-title":"Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol","volume":"9","author":"Nichols","year":"1991","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3171\/jns.1991.74.3.0433","article-title":"Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma","volume":"74","author":"Packer","year":"1991","journal-title":"Journal of Neurosurgery"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1200\/JCO.2006.06.4980","article-title":"Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma","volume":"24","author":"Packer","year":"2006","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1470-2045(08)70069-X","article-title":"High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial","volume":"9","author":"Pearson","year":"2008","journal-title":"Lancet Oncology"},{"issue":"8","key":"10.1002\/14651858.CD010181.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1200\/JCO.1987.5.8.1221","article-title":"Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapy","volume":"5","author":"Pendergrass","year":"1987","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD010181.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ejca.2003.06.003","article-title":"Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology-SIOPEL 2","volume":"40","author":"Perilongo","year":"2004","journal-title":"European Journal of Cancer"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1200\/JCO.2000.18.22.3819","article-title":"Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach - results of the first prospective study of the International Society of Pediatric Oncology","volume":"18","author":"Pritchard","year":"2000","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/pbc.20310","article-title":"Long-term medical effects of childhood and adolescent rhabdomyosarcoma: a report from the childhood cancer survivor study","volume":"44","author":"Punyko","year":"2005","journal-title":"Pediatric Blood & Cancer"},{"issue":"2","key":"10.1002\/14651858.CD010181.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/clpt.2013.80","article-title":"Replication of TPMT and ABCC3 genetic variants highly associated with cisplatin-induced hearing loss in children","volume":"94","author":"Pussegoda","year":"2013","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD010181.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/(SICI)1096-911X(199910)33:4<362::AID-MPO4>3.0.CO;2-I","article-title":"Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: a descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-II and - III. IRS Group of the Children's Cancer Group and the Pediatric Oncology Group","volume":"33","author":"Raney","year":"1999","journal-title":"Medical and Pediatric Oncology"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0113|cit113","first-page":"733","article-title":"Identification of genetic markers of severe hearing loss in children receiving cisplatin","author":"Rassekh","year":"2009","journal-title":"Pediatric Blood & Cancer"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0114|cit114","doi-asserted-by":"crossref","unstructured":"Rednam S Scheurer M Adesina A Lau C Okcu M Glutathione s-transferase P1 single nucleotide polymorphism predicts permanent ototoxicity in children with medulloblastoma (i125) International Symposium on Pediatric Neuro-Oncology 2012","DOI":"10.1002\/pbc.24366"},{"issue":"4","key":"10.1002\/14651858.CD010181.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/pbc.24366","article-title":"Glutathione S-transferase P1 single nucleotide polymorphism predicts permanent ototoxicity in children with medulloblastoma","volume":"60","author":"Rednam","year":"2013","journal-title":"Pediatric Blood & Cancer"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1177\/001857870303800702","article-title":"Bleomycin, etoposide, and cisplatin (BEP) regimen for testicular cancer","volume":"38","author":"Roark","year":"2003","journal-title":"Hospital Pharmacy"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0167-8140(84)80059-6","article-title":"Improved survival in neuroblastoma using multimodality therapy","volume":"2","author":"Rosen","year":"1984","journal-title":"Radiotherapy and Oncology"},{"issue":"12","key":"10.1002\/14651858.CD010181.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/ng.478","article-title":"Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy","volume":"41","author":"Ross","year":"2009","journal-title":"Nature Genetics"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1310\/hpj4207-605","article-title":"Doxorubicin and cisplatin regimen for high-grade osteosarcoma or malignant fibrous histiocytoma (MFH) of the bone","volume":"42","author":"Rutledge","year":"2007","journal-title":"Hospital Pharmacy"},{"issue":"9","key":"10.1002\/14651858.CD010181.pub2-BIB0120|cit120","first-page":"1599","article-title":"Carboplatin and etoposide in acute myeloid leukemia","volume":"8","author":"Sanz","year":"1994","journal-title":"Leukemia"},{"issue":"9","key":"10.1002\/14651858.CD010181.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/1097-0142(19901101)66:9<1879::AID-CNCR2820660905>3.0.CO;2-L","article-title":"Treatment of advanced neuroblastoma with emphasis on intensive induction chemotherapy. A report from the Study Group of Japan","volume":"66","author":"Sawaguchi","year":"1990","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0959-8049(97)10045-4","article-title":"Germ cell tumours of the central nervous system: treatment consideration based on 111 cases and their long-term clinical outcomes","volume":"34","author":"Sawamura","year":"1998","journal-title":"European Journal of Cancer"},{"issue":"6","key":"10.1002\/14651858.CD010181.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1200\/JCO.1989.7.6.754","article-title":"Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation","volume":"7","author":"Schell","year":"1989","journal-title":"Journal of Clinical Oncology"},{"issue":"8","key":"10.1002\/14651858.CD010181.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/neuonc\/nou006","article-title":"Examination of risk factors for intellectual and academic outcomes following treatment for pediatric medulloblastoma","volume":"16","author":"Schreiber","year":"2014","journal-title":"Neuro-Oncology"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0125|cit125","unstructured":"Sefi E Brock P Chang K Neuwelt E Knight K Rajput K Validation of the SIOP Boston ototoxicity scale - an international scale for the evaluation of platinum-induced ototoxicity in children (P-0486) Pediatric Blood & Cancer 2013 167"},{"issue":"5","key":"10.1002\/14651858.CD010181.pub2-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1177\/014556131109000506","article-title":"The role of ultrahigh-frequency audiometry in the early detection of systemic drug-induced hearing loss","volume":"90","author":"Singh Chauhan","year":"2011","journal-title":"Ear Nose & Throat Journal"},{"issue":"3","key":"10.1002\/14651858.CD010181.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0360-3016(02)04212-8","article-title":"In regard to Huang et al.: intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity. IJROBP 2002;52:599-605","volume":"55","author":"Soomal","year":"2003","journal-title":"International Journal of Radiation Oncology Biology Physics"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0140-6736(97)02307-6","article-title":"Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup","volume":"350","author":"Souhami","year":"1997","journal-title":"Lancet"},{"issue":"13","key":"10.1002\/14651858.CD010181.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.2217\/pgs.14.112","article-title":"Genetic variation in Otos is associated with cisplatin-induced ototoxicity","volume":"15","author":"Spracklen","year":"2014","journal-title":"Pharmacogenomics"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0130|cit130","unstructured":"Steinherz P Tan C Ghavimi F Helson L Rosen G Wollner N VAB III combination chemotherapy in childhood malignancies (C-231) Proceedings of the American Association for Cancer Research 1977"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0131|cit131","unstructured":"Stewart D Wallace S Leavens M Phase I study of intracarotid (IC) cis-diamminedichloroplatinum (DDP) in patients with intracerebral tumors (ICT) Proceedings of the American Association for Cancer Research 1981 749"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/0022-3468(94)90360-3","article-title":"What is the benefit of aggressive chemotherapy for advanced neuroblastoma with N-myc amplification? A report from the Japanese study group for the treatment of advanced neuroblastoma","volume":"29","author":"Suita","year":"1994","journal-title":"Journal of Pediatric Surgery"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0133|cit133","first-page":"659","article-title":"Treatment of refractory non-Hodgkin's lymphomas of unfavorable histology with teniposide, cytarabine, and cisplatin","volume":"71","author":"Tseng","year":"1987","journal-title":"Cancer Treatment Reports"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0134|cit134","first-page":"1857","article-title":"Toxic effects of cisplatin in treatment of malignant bone and soft tissue tumors","volume":"13","author":"Umeda","year":"1986","journal-title":"Japanese Journal of Cancer and Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD010181.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/pbc.25230","article-title":"Etoposide and carbo- or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: a large retrospective study","volume":"62","author":"Maldegem","year":"2015","journal-title":"Pediatric Blood & Cancer"},{"issue":"27","key":"10.1002\/14651858.CD010181.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1200\/JCO.2012.43.5677","article-title":"Carboplatin dosing in infants with retinoblastoma: a case for therapeutic drug monitoring","volume":"30","author":"Veal","year":"2012","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0305-7372(82)80077-7","article-title":"Cis-dichlorodiammineplatinum (II) (cis-platinum) and etoposide for patients with refractory lymphomas","volume":"9","author":"Heyden","year":"1982","journal-title":"Cancer Treatment Reviews"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.ejca.2009.01.015","article-title":"Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91","volume":"45","author":"Hoff","year":"2009","journal-title":"European Journal of Cancer"},{"issue":"33","key":"10.1002\/14651858.CD010181.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"e356","DOI":"10.1200\/JCO.2011.41.4359","article-title":"Anti-cytotoxic T-cell lymphocyte antigen-4-induced regression of spinal cord metastases in association with renal failure, atypical pneumonia, vision loss, and hearing loss","volume":"30","author":"Voskens","year":"2012","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD010181.pub2-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/pbc.23025","article-title":"Auditory complications in childhood cancer survivors: a report from the childhood cancer survivor study","volume":"57","author":"Whelan","year":"2011","journal-title":"Pediatric Blood & Cancer"},{"issue":"4","key":"10.1002\/14651858.CD010181.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"288","DOI":"10.7196\/SAMJ.7389","article-title":"High prevalence of cisplatin-induced ototoxicity in Cape Town, South Africa","volume":"104","author":"Whitehorn","year":"2014","journal-title":"South African Medical Journal"},{"issue":"8","key":"10.1002\/14651858.CD010181.pub2-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/1097-0142(19901015)66:8<1703::AID-CNCR2820660809>3.0.CO;2-V","article-title":"Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (study COSS-86)","volume":"66","author":"Winkler","year":"1990","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/978-1-4615-3518-8_32","article-title":"Treatment of osteosarcoma: experience of the Cooperative Osteosarcoma Study Group (COSS)","volume":"62","author":"Winkler","year":"1993","journal-title":"Cancer Treatment and Research"},{"issue":"3","key":"10.1002\/14651858.CD010181.pub2-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/ng.3217","article-title":"Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss","volume":"47","author":"Xu","year":"2015","journal-title":"Nature Genetics"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0145|cit145","first-page":"851","article-title":"Gender is a predictor of cisplatin ototoxicity","author":"Yancey","year":"2010","journal-title":"Pediatric Blood & Cancer"},{"issue":"1","key":"10.1002\/14651858.CD010181.pub2-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/pbc.24138","article-title":"Risk factors for cisplatin-associated ototoxicity in pediatric oncology patients","volume":"59","author":"Yancey","year":"2012","journal-title":"Pediatric Blood & Cancer"},{"issue":"2","key":"10.1002\/14651858.CD010181.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/clpt.2013.121","article-title":"The role of inherited TPMT and COMT genetic variation in cisplatin-induced ototoxicity in children with cancer","volume":"94","author":"Yang","year":"2013","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/pbc.21713","article-title":"Outcomes of the POG 9340\/9341\/9342 trials for children with high-risk neuroblastoma: a report from the children's oncology group","volume":"51","author":"Zage","year":"2008","journal-title":"Pediatric Blood & Cancer"},{"issue":"9-10","key":"10.1002\/14651858.CD010181.pub2-BIB0149|cit149","first-page":"815","article-title":"Phase II trial of cisplatin in refractory childhood cancer: Children's Cancer Study Group Report","volume":"65","author":"Baum","year":"1981","journal-title":"Cancer Treatment Reports"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0150|cit150","doi-asserted-by":"crossref","unstructured":"Clemens E de Vries AC van Dulmen-den Broeder E van Grotel M Pluijm SF Tissing WJ The influence of co-medication on platinum-related ototoxicity in long-term survivors of childhood cancer: a descriptive DCOG study 14th International Conference on Long-Term Complications of Treatment of Children and Adolescents for Cancer 2015 69 (abstract 111)","DOI":"10.1016\/j.ejca.2016.09.023"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0151|cit151","first-page":"1005","article-title":"Preirradiation carboplatin and etoposide in the treatment of paediatric medulloblastoma in a single institution","author":"Clerico","year":"2010","journal-title":"Pediatric Blood & Cancer"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0152|cit152","first-page":"875","article-title":"Management of young children newly diagnosed with CNS embryonal tumors: 18 years of three sequential irradiation-avoiding chemotherapy studies - The \"Head Start\" protocols","author":"Finlay","year":"2009","journal-title":"Neuro-Oncology Conference"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"7621","DOI":"10.1200\/JCO.2005.09.095","article-title":"Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group","volume":"23","author":"Geyer","year":"2005","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0154|cit154","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2013.31.15_suppl.10038","article-title":"Survival, surgical resectability, and late effects in the hepatoblastoma patients treated by cisplatin plus pirarubicin (CITA) chemotherapy (10038)","author":"Hiyama","year":"2013","journal-title":"Annual Meeting of the American Society of Clinical Oncology"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0155|cit155","first-page":"S196","article-title":"Long term audiologic outcomes in children treated with platinum chemotherapy","author":"Knight","year":"2014","journal-title":"Pediatric Blood & Cancer"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0156|cit156","first-page":"853","article-title":"Sensory status of childhood brain tumors survivors (PQ.002)","author":"Korzeniewska","year":"2009","journal-title":"Pediatric Blood & Cancer"},{"issue":"4","key":"10.1002\/14651858.CD010181.pub2-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-2008-1043883","article-title":"Preradiation chemotherapy of children and young adults with malignant brain tumors: results of the German pilot trial HIT'88\/'89","volume":"210","author":"Kuhl","year":"1998","journal-title":"Klinische Padiatrie"},{"issue":"2","key":"10.1002\/14651858.CD010181.pub2-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/cncr.22004","article-title":"Ototoxicity from high-dose use of platinum compounds in patients with neuroblastoma","volume":"107","author":"Kushner","year":"2006","journal-title":"Cancer"},{"issue":"26","key":"10.1002\/14651858.CD010181.pub2-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1200\/JCO.2011.39.8719","article-title":"Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial","volume":"30","author":"Lannering","year":"2012","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"S113","DOI":"10.1016\/j.ijrobp.2011.06.231","article-title":"The impact of ototoxic chemotherapy on hearing loss after radiation therapy in children with brain tumors","author":"Merchant","year":"2011","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0161|cit161","unstructured":"Nirenberg A Cacavio A Bru G Gaparros B Rosen G Ambulatory high dose cisplatinum (HD-DDP) with mannitol diuresis: a treatment system without renal, auditory or biochemical toxicity C-766 Proceedings of the American Association for Cancer Research 1981"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/mpo.2950240308","article-title":"Treatment combined with bone marrow transplantation for advanced neuroblastoma: an analysis of patients who were pretreated intensively with the protocol of the study group of Japan","volume":"24","author":"Ohnuma","year":"1995","journal-title":"Medical and Pediatric Oncology"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"abstract 10038","DOI":"10.1200\/jco.2014.32.15_suppl.10038","article-title":"Association of genetic variants involved in drug metabolism and transport with efficacy and toxicity of chemotherapeutic treatment in osteosarcoma patients","volume":"32: 5s","author":"Vos","year":"2014","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0164|cit164","unstructured":"Weiss A Kasteler R Kuonen R Wengenroth L Scheinemann K Grotzer M Hearing impairment in Swiss childhood cancer survivors 14th International Conference on Long-Term Complications of Treatment of Children and Adolescents for Cancer 2015 69-70 (abstract 112)"},{"issue":"8","key":"10.1002\/14651858.CD010181.pub2-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3766\/jaaa.25.8.6","article-title":"Challenges in ototoxicity monitoring in the pediatric oncology population","volume":"25","author":"Bass","year":"2014","journal-title":"Journal of the American Academy of Audiology"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0166|cit166","first-page":"123","article-title":"Late effects of cancer treatment and current protective measures","volume-title":"Cancer in Children","author":"Jenney","year":"2005"},{"issue":"2","key":"10.1002\/14651858.CD010181.pub2-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/MPH.0b013e31815d1d83","article-title":"Hearing loss in pediatric oncology patients receiving carboplatin-containing regimens","volume":"30","author":"Dean","year":"2008","journal-title":"Journal of Pediatric Hematology\/Oncology"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0168|cit168","unstructured":"Eloxatin Summary of Product Characteristics www.sanofi-aventis.co.uk\/products\/Eloxatin_SPC.pdf (accessed 2 March 2010)"},{"issue":"1","key":"10.1002\/14651858.CD010181.pub2-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"744","DOI":"10.7326\/0003-4819-91-5-744","article-title":"Furosemide-induced ototoxicity","volume":"91","author":"Gallagher","year":"1979","journal-title":"Annals of Internal Medicine"},{"issue":"9209","key":"10.1002\/14651858.CD010181.pub2-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(00)02044-4","article-title":"Circulating plasma platinum more than 10 years after cisplatin treatment for testicular cancer","volume":"355","author":"Gietema","year":"2000","journal-title":"Lancet"},{"issue":"7","key":"10.1002\/14651858.CD010181.pub2-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1542\/pir.25.7.224","article-title":"Pediatric audiology: a review","volume":"25","author":"Gregg","year":"2004","journal-title":"Pediatrics in Review"},{"issue":"9303","key":"10.1002\/14651858.CD010181.pub2-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(02)07500-1","article-title":"Cohort studies: marching towards outcomes","volume":"359","author":"Grimes","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0173|cit173","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"4","key":"10.1002\/14651858.CD010181.pub2-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000120794","article-title":"Hyperfractionated irradiation and concurrent cisplatin in brain stem tumors: a Pediatric Oncology Group pilot study (9139)","volume":"20","author":"Kadota","year":"1994","journal-title":"Pediatric Neurosurgery"},{"issue":"34","key":"10.1002\/14651858.CD010181.pub2-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"8588","DOI":"10.1200\/JCO.2004.00.5355","article-title":"Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development","volume":"23","author":"Knight","year":"2005","journal-title":"Journal of Clinical Oncology"},{"issue":"3","key":"10.1002\/14651858.CD010181.pub2-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1001\/jama.1994.03520030076032","article-title":"Users' guides to the medical literature. V. How to use an article about prognosis. Evidence-Based Medicine Working Group","volume":"272","author":"Laupacis","year":"1994","journal-title":"JAMA"},{"issue":"10","key":"10.1002\/14651858.CD010181.pub2-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1200\/JCO.2011.39.4254","article-title":"A cautionary tale: dosing chemotherapy in infants with retinoblastoma","volume":"30","author":"Leahey","year":"2012","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0178|cit178","unstructured":"National Health Service Hearing loss - causes www.nhs.uk\/Conditions\/hearing-impairment\/Pages\/causes.aspx"},{"issue":"10","key":"10.1002\/14651858.CD010181.pub2-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1200\/JCO.2011.36.9744","article-title":"Carboplatin-associated ototoxicity in children with retinoblastoma","volume":"30","author":"Qaddoumi","year":"2012","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD010181.pub2-BIB0180|cit180","first-page":"19","article-title":"Ototoxicity in patients receiving cisplatin: importance of dose and method of drug administration","volume":"66","author":"Reddel","year":"1982","journal-title":"Cancer Treatment Reports"},{"key":"10.1002\/14651858.CD010181.pub2-BIB0181|cit181","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"16","key":"10.1002\/14651858.CD010181.pub2-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1016\/j.ejca.2004.08.002","article-title":"Best practice in assessing ototoxicity in children with cancer","volume":"40","author":"Skinner","year":"2004","journal-title":"European Journal of Cancer"},{"issue":"5","key":"10.1002\/14651858.CD010181.pub2-BIB0183|cit183","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009219.pub2","article-title":"Medical interventions for the prevention of platinum-induced hearing loss in children with cancer","author":"As","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD010181.pub2-BIB0184|cit184","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010885.pub2","article-title":"Different infusion durations for preventing platinum-induced hearing loss in children with cancer","author":"As","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD010181.pub2-BIB0185|cit185","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009219.pub3","article-title":"Medical interventions for the prevention of platinum-induced hearing loss in children with cancer","author":"As","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD010181.pub2-BIB0186|cit186","first-page":"2205","article-title":"Influence of cellular factors and pharmacokinetics on the formation of platinum-DNA adducts in leukocytes of children receiving cisplatin therapy","volume":"7","author":"Veal","year":"2001","journal-title":"Clinical Cancer Research"},{"issue":"11","key":"10.1002\/14651858.CD010181.pub2-BIB0187|cit187","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010181","article-title":"Platinum-induced hearing loss after treatment for childhood cancer","author":"As","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD010181.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T06:49:10Z","timestamp":1704264550000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010181.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Childhood Cancer Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,8,3]]},"references-count":187,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010181.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,3]]}}}